首页
登录
职称英语
Doctors are to begin a trial of a drug treatment that could double the time
Doctors are to begin a trial of a drug treatment that could double the time
游客
2024-02-09
58
管理
问题
Doctors are to begin a trial of a drug treatment that could double the time transplanted organs survive in the body. The 20-minute procedure effectively coats donor organs in a protective shield that stops them being rejected by the patient’s immune system.
The treatment is expected to prolong the time that organs remain healthy in patients’ bodies and also increase their shelf-life(保存期限), so they can be stored for longer or transported further before being used. If the treatment works, it could ease the burden on organ transplant services, which face an increasing gap between the supply and demand for donor organs.
People who receive transplants must take drugs to suppress their immune systems, but the body still reacts enough to cause transplants to fail sooner than they should. A healthy transplanted kidney lasts on average only 10 years, around one third of the time it should last. Organs such as hearts and livers fail even sooner. The consequence is that patients who have had one donor organ often need another.
The new treatment, developed by researchers at King’s College London, is based on the defense mechanism healthy organs use to shield themselves from the immune system. Studies suggest the procedure could extend the life of an implanted kidney by around seven years. The scientists believe the treatment will also extend the shelf-life of donor organs, increasing the time they survive outside the body from no more than 24 hours to several days. This could reduce wastage and double the number of organs that work properly once they are transplanted, doctors said. In early tests, only a fifth of organs worked properly after being stored on ice for 16 hours, compared with 50% of those treated with mirococept(药物:米罗西普).
A recent pilot study of the treatment on 16 patients found it was safe to use. Patients who receive donated organs treated with mirococept will still need to take drugs to suppress their immune systems, but doctors said an aim of their research was to see if the use of current drugs, which can increase a patient’s risk of cancer, can be reduced. [br] Why patients who are treated with the old treatment often need another donor organ?
选项
A、Because they are painful after transplanting.
B、Because taking drugs can ease the burden of organs.
C、Because the body still reacts enough to cause transplants to fail.
D、Because the donor organs will be rejected by the immune system.
答案
C
解析
推理判断题。由定位句中的consequence可知题干为结果,原因应从定位句的前文查找。原文提到手术后,病人身体会有排异反应,因此需要服药来抑制免疫系统,但是即使服药,身体仍会产生排异反应,从而使移植器官不能工作,故病人需要再进行一次移植手术,因此答案为C)。
转载请注明原文地址:https://tihaiku.com/zcyy/3435096.html
相关试题推荐
[originaltext]PeoplefortheEthicalTreatmentofAnimals,theanimalwelfa
Thedoctorsaysthat______(这项新的疗法有助于防止艾滋病的发展).thenewtreatmentwillhelppreven
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
随机试题
Around120yearsago,Ebbinghausbeganhisstudyofmemory.He【B1】______stu
It’struethat"Asmallchangecanmakeabigdifference"inourlife.Abet
动脉瘤的MRI表现,错误的是A.无血栓动脉瘤T1WI和T2WI都为无信号或低信号
A.横切口 B.纵切口 C.放射状切口 D.弧形切口 E."S"形切口乳
属于氨基酸类的激素是A:GHB:胃肠激素C:前列腺素D:甲状腺激素E:性
下列关于信用卡说法不正确的是()。A:信用卡有广义信用卡和狭义信用卡之分 B:
配制的试液应装在适宜的试剂瓶中储存,以下试液最应该保存在聚乙烯塑料瓶中的是A.盐
2021年1—4月份,规模以上非金属矿物制品业利润总额同比增量约是非金属矿采
不同家庭生命周期的理财重点不同,资产配置也应有所不同,其中对收益性需求最大,投资
对同一借款客户的贷款余额与商业银行资本余额的比例不得超过()。A、
最新回复
(
0
)